Literature DB >> 27679423

Hypoxia and low-dose inflammatory stimulus synergistically enhance bone marrow mesenchymal stem cell migration.

Yang Yu1,2, Yuan Yin1, Rui-Xin Wu1, Xiao-Tao He1, Xi-Yu Zhang1, Fa-Ming Chen1.   

Abstract

OBJECTIVES: Cell migration is necessary for numerous physiological cell processes. Although either inflammatory or hypoxic stimuli of certain dose and duration have positive influence on cell migration, their combination has not been shown to result in a synergistic effect.
MATERIALS AND METHODS: In this study, we investigated combined effects of hypoxia and low-dose inflammatory stimulus (one-tenth of that of a previously used concentration) on migration of human bone marrow-derived mesenchymal stem cells (BMMSCs).
RESULTS: Our results from real-time PCR, Western blot analysis and an immunofluorescence assay, showed that dual stimulation up-regulated CXCR4 expression. Based on tablet scratch experimentation and transwell assay, the dual stimuli exhibited greater positive effects on cell migration than a single inflammatory or hypoxic stimulus. When effects of various pre-treatments on cell proliferation, differentiation and immunosuppression were screened, cells subjected to the hypoxic stimulus or dual stimuli had increased cell proliferation, while short-term inflammatory stimulus and/or hypoxic stimulus had no negative effect on cell differentiation and immunosuppression.
CONCLUSIONS: These findings suggest that the combination of hypoxia and low-dose inflammatory stimuli enhances the potential of BMMSCs to migrate, thus identifying cell pre-treatment conditions that could enhance future stem cell-based therapeutics.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27679423      PMCID: PMC6529070          DOI: 10.1111/cpr.12309

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  33 in total

1.  Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases.

Authors:  Bo-Ra Son; Leah A Marquez-Curtis; Magda Kucia; Marcin Wysoczynski; A Robert Turner; Janina Ratajczak; Mariusz Z Ratajczak; Anna Janowska-Wieczorek
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

2.  Hypoxia simultaneously alters satellite cell-mediated angiogenesis and hepatocyte growth factor expression.

Authors:  K L Flann; C R Rathbone; L C Cole; X Liu; R E Allen; R P Rhoads
Journal:  J Cell Physiol       Date:  2014-05       Impact factor: 6.384

3.  Effects of short-term inflammatory and/or hypoxic pretreatments on periodontal ligament stem cells: in vitro and in vivo studies.

Authors:  Yang Yu; Chun-Sheng Bi; Rui-Xin Wu; Yuan Yin; Xi-Yu Zhang; Ping-Heng Lan; Fa-Ming Chen
Journal:  Cell Tissue Res       Date:  2016-06-15       Impact factor: 5.249

Review 4.  Prospects for translational regenerative medicine.

Authors:  Fa-Ming Chen; Yi-Min Zhao; Yan Jin; Songtao Shi
Journal:  Biotechnol Adv       Date:  2011-11-27       Impact factor: 14.227

5.  Involvement of TNF-α in differential gene expression pattern of CXCR4 on human marrow-derived mesenchymal stem cells.

Authors:  Rozita Ziaei; Maryam Ayatollahi; Ramin Yaghobi; Zeinab Sahraeian; Nosratollah Zarghami
Journal:  Mol Biol Rep       Date:  2014-01-07       Impact factor: 2.316

6.  In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors.

Authors:  Sun Jin Baek; Sung Keun Kang; Jeong Chan Ra
Journal:  Exp Mol Med       Date:  2011-10-31       Impact factor: 8.718

7.  The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities.

Authors:  Adriana López Ponte; Emeline Marais; Nathalie Gallay; Alain Langonné; Bruno Delorme; Olivier Hérault; Pierre Charbord; Jorge Domenech
Journal:  Stem Cells       Date:  2007-03-29       Impact factor: 6.277

8.  GSK3β is a checkpoint for TNF-α-mediated impaired osteogenic differentiation of mesenchymal stem cells in inflammatory microenvironments.

Authors:  Xiangwei Kong; Yan Liu; Ruidong Ye; Bin Zhu; Yuan Zhu; Xianghui Liu; Chenghu Hu; Hailang Luo; Yongjie Zhang; Yin Ding; Yan Jin
Journal:  Biochim Biophys Acta       Date:  2013-08-02

9.  Comparison of mesenchymal stem cells derived from gingival tissue and periodontal ligament in different incubation conditions.

Authors:  Hao Yang; Li-Na Gao; Ying An; Cheng-Hu Hu; Fang Jin; Jun Zhou; Yan Jin; Fa-Ming Chen
Journal:  Biomaterials       Date:  2013-06-13       Impact factor: 12.479

10.  Combination of inflammation-related cytokines promotes long-term muscle stem cell expansion.

Authors:  Xin Fu; Jun Xiao; Yuning Wei; Sheng Li; Yan Liu; Jie Yin; Kun Sun; Hao Sun; Huating Wang; Zongkang Zhang; Bao-Ting Zhang; Chun Sheng; Hongyan Wang; Ping Hu
Journal:  Cell Res       Date:  2015-05-15       Impact factor: 25.617

View more
  9 in total

1.  Forkhead box O1 (FOXO1) controls the migratory response of Toll-like receptor (TLR3)-stimulated human mesenchymal stromal cells.

Authors:  Sun Hwa Kim; Amitabh Das; Hae In Choi; Ki Hoon Kim; Jin Choul Chai; Mi Ran Choi; Bert Binas; Kyoung Sun Park; Young Seek Lee; Kyoung Hwa Jung; Young Gyu Chai
Journal:  J Biol Chem       Date:  2019-04-03       Impact factor: 5.157

2.  Influences of age-related changes in mesenchymal stem cells on macrophages during in-vitro culture.

Authors:  Yuan Yin; Rui-Xin Wu; Xiao-Tao He; Xin-Yue Xu; Jia Wang; Fa-Ming Chen
Journal:  Stem Cell Res Ther       Date:  2017-06-24       Impact factor: 6.832

3.  Preconditioning of umbilical cord-derived mesenchymal stem cells by rapamycin increases cell migration and ameliorates liver ischaemia/reperfusion injury in mice via the CXCR4/CXCL12 axis.

Authors:  Jun Zheng; Hui Li; Liying He; Yiming Huang; Jianye Cai; Liang Chen; Chaorong Zhou; Hongyuan Fu; Tongyu Lu; Yingcai Zhang; Jia Yao; Yang Yang
Journal:  Cell Prolif       Date:  2018-12-10       Impact factor: 6.831

4.  Osteoarthritic Milieu Affects Adipose-Derived Mesenchymal Stromal Cells.

Authors:  Cristina Manferdini; Francesca Paolella; Elena Gabusi; Luca Cattini; Markus Rojewski; Hubert Schrezenmeier; Olga Addimanda; Riccardo Meliconi; Gina Lisignoli
Journal:  J Orthop Res       Date:  2019-08-30       Impact factor: 3.494

5.  Important role of the SDF-1/CXCR4 axis in the homing of systemically transplanted human amnion-derived mesenchymal stem cells (hAD-MSCs) to ovaries in rats with chemotherapy-induced premature ovarian insufficiency (POI).

Authors:  Li Ling; Jiying Hou; Dandan Liu; Dongyuan Tang; Yanqin Zhang; Qianru Zeng; Heng Pan; Ling Fan
Journal:  Stem Cell Res Ther       Date:  2022-02-23       Impact factor: 6.832

Review 6.  The role of hypoxia in stem cell regulation of the central nervous system: From embryonic development to adult proliferation.

Authors:  Gaifen Li; Jia Liu; Yuying Guan; Xunming Ji
Journal:  CNS Neurosci Ther       Date:  2021-12       Impact factor: 5.243

7.  Ginsenoside Rb1 Modulates the Migration of Bone-Derived Mesenchymal Stem Cells through the SDF-1/CXCR4 Axis and PI3K/Akt Pathway.

Authors:  Yimei Liu; Ninghua Liu; Xiangyang Li; Zhe Luo; Jing Zhang
Journal:  Dis Markers       Date:  2022-03-10       Impact factor: 3.434

8.  Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors.

Authors:  Jiaying Lin; Qianqian Zhu; Jialyu Huang; Renfei Cai; Yanping Kuang
Journal:  Stem Cells Int       Date:  2020-02-20       Impact factor: 5.443

9.  Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions.

Authors:  Yuichi Kojima; Atsunori Tsuchiya; Masahiro Ogawa; Shunsuke Nojiri; Suguru Takeuchi; Takayuki Watanabe; Kenji Nakajima; Yukio Hara; Junji Yamashita; Junichi Kikuta; Masaaki Takamura; Masaru Ishii; Shuji Terai
Journal:  Regen Ther       Date:  2019-09-20       Impact factor: 3.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.